Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BELEN MARIA HERRERO-MUJIC

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1114959046
CMS profile
95668
Location
TAMPA, FL

General Payments · PY2018–2024

$1,333.90

  • Reported across 68 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$306.62

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $306.62 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ABBVIE INC. $116.87 5
GlaxoSmithKline, LLC. $69.57 4
Abbott Laboratories $29.57 1
Bayer HealthCare Pharmaceuticals Inc. $24.18 1
Lilly USA, LLC $22.93 1
Novo Nordisk AS $22.54 1
PFIZER INC. $20.96 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $170.52 12
PY2019 $85.32 4
PY2020 $58.48 3
PY2021 $176.03 11
PY2022 $174.54 8
PY2023 $362.39 16
PY2024 $306.62 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Abbott Laboratories $29.57 01/24/2024 Food and Beverage Undisputed 01/23/2026 1124853753 CMS
ABBVIE INC. $23.22 01/06/2024 Food and Beverage Undisputed 01/23/2026 1103911337 CMS
ABBVIE INC. $31.28 02/07/2024 Food and Beverage Undisputed 01/23/2026 1103911339 CMS
ABBVIE INC. $13.23 05/15/2024 Food and Beverage Undisputed 01/23/2026 1103911341 CMS
ABBVIE INC. $15.64 07/31/2024 Food and Beverage Undisputed 01/23/2026 1103911343 CMS
ABBVIE INC. $33.50 08/21/2024 Food and Beverage Undisputed 01/23/2026 1103911345 CMS
Bayer Healthcare Pharmaceuticals Inc. $24.18 02/02/2024 Food and Beverage Undisputed 01/23/2026 1086160346 CMS
GlaxoSmithKline, LLC. $15.13 04/05/2024 Food and Beverage Undisputed 01/23/2026 1116044371 CMS
GlaxoSmithKline, LLC. $17.25 05/11/2024 Food and Beverage Undisputed 01/23/2026 1116524212 CMS
GlaxoSmithKline, LLC. $18.10 08/17/2024 Food and Beverage Undisputed 01/23/2026 1116640312 CMS
GlaxoSmithKline, LLC. $19.09 09/27/2024 Food and Beverage Undisputed 01/23/2026 1115948192 CMS
Lilly USA, LLC $22.93 11/01/2024 Food and Beverage Undisputed 01/23/2026 1136059738 CMS
Novo Nordisk Inc $22.54 02/16/2024 Food and Beverage Undisputed 01/23/2026 1097340752 CMS
PFIZER INC. $20.96 04/03/2024 Food and Beverage Undisputed 01/23/2026 1131420038 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.